SAWC Preview

SAWC Oral Abstracts Preview

April 26–29, 2009
Gaylord Texan Resort
Dallas, Texas
www.sawc.net

More than 380 abstracts were submitted for presentation at the 2009 SAWC/WHS. Of those, 24 were accepted for oral presentation. The following is a preview of a few abstracts that will be presented during sessions 29–31, and sessions 42–44. The accepted poster presentations may be viewed throughout the entire meeting and during the scheduled poster session, which will be held Monday April 27 from 7:30am–9:30am. The 2nd annual Poster Gala and Awards will



Oral Abstracts Preview

A clinical investigation into the relationship between increased periwound skin temperature and localized wound infection

Marjorie Fierheller, RN, BScN, Ms(c); Dr. Michael Clark; Dr. RG Sibbald, Chronic Wound Healing Clinic, Mississauga, Ontario

Many studies relate the presence of chronic wound infection to reduced strength of healing tissue and delayed healing. Although failure to heal may be the result of many coexisting factors, infection is often found to be a significant contributor.
Increased local temperature is a classic sign of wound inf



Exhibitors Preview

BlueSky Medical Group, Inc. – Booths 611 and 613

BlueSky Medical developed the Versatile 1™ Wound Vacuum System, a safe and cost-effective approach that may promote wound healing. BlueSky is a leader in suction technologies that emphasize wound applications such as negative pressure wound therapy. Our new V1STA Versatile 1™ portable pump features multiple safety alarms and automatic high-vacuum release in a small, quiet, portable product. Sealing kits and skin products also are available — Lanabalm, for example, assists with problem cracked an



SAWC Oral Abstract Preview

The development of an infected acute wound porcine model
D. Boone, MD, E. Braitman, MD, J. Afthinos, MD, C. Gendics, RN, E. Sordillo, MD, PhD, G. Todd, MD, J. Lantis, MD
Introduction: To assess the many potential antimicrobial agents available as well as pro-growth agents, we found it necessary to develop a medium size animal model. While there are many animal models for infection, many of them include a wound inhibiting therapy, as an adjunct. In addition, in most models there is not a delay between inoculation and treatment. Therefore,



SAWC Exhibitor Preview

Anacapa Technologies, Inc. – Booth 723

Anasept Skin & Wound Antiseptic is a non-cytotoxic, extremely fast-acting, antimicrobial skin and wound cleanser with broad-spectrum, bactericidal (including the antibiotic resistant strains MRSA & VRE, and Acinetobacter baumanii) , fungicidal and virucidal properties. Anasept is available in both spray and pour bottle applicators.

Anasept Antiseptic Skin & Wound Gel is an extremely safe, clear, long-acting, topical antimicrobial hydrogel with broad-spectrum, bactericidal